PeriphEX Corp.

Over 50 millions Americans suffer from Peripheral Neuropathy. This very debilitating condition has no satisfactory treatment option.

  • Stage Full Product Ready
  • Industry Consumer Products
  • Location Austin, TX, USA
  • Currency USD
  • Founded October 2018
  • Employees 4
  • Incorporation Type C-corp
  • Website periphex.com

Company Summary

1 in 10 Americans suffers from nerve pain or numbness. Peripheral neuropathy is a very debilitating condition with no satisfactory treatment. PeriphEX has developed NoxyPure, a Hydrogel loaded with nanobubbles of gas that provides superior relief of symptoms and improvement of nerve function with no complications or side effects. We have strong clinical data and promising initial sales for this consumer product sold through healthcare providers.

Team

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free